BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 29, Issue 8
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (9284)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.
Item 
Count 
PDF395
WORD53
HTML6724
Figures (1-1)324
Tables (1-2)432
 Sum=7928
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse181
Download467
 Sum=648
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse193
Download515
 Sum=708
Feb 28, 2023 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, Imbriani S, Claar E, Cozzolino D, Sasso FC, Marrone A, Adinolfi LE, Rinaldi L. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroenterol 2023; 29(8): 1243-1260 [PMID: 36925456 DOI: 10.3748/wjg.v29.i8.1243]
URL: https://www.wjgnet.com/1007-9327/full/v29/i8/1243.htm
Number Citing Articles
1
Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine. World Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424
2
Abdullah Altaf, Yutaka Endo, Muhammad M. Munir, Muhammad Muntazir M. Khan, Zayed Rashid, Mujtaba Khalil, Alfredo Guglielmi, Francesca Ratti, Hugo Marques, François Cauchy, Vincent Lam, George Poultsides, Minoru Kitago, Irinel Popescu, Guillaume Martel, Ana Gleisner, Tom Hugh, Feng Shen, Itaru Endo, Timothy M. Pawlik. Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma. HPB 2024; 26(8): 1040 doi: 10.1016/j.hpb.2024.05.006
3
Zhanao He, Jie Zhang, Wukui Huang. Diagnostic role and immune correlates of programmed cell death-related genes in hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47560-4
4
Hyun Joo Lee, Moon Seok Choi, Byeong Geun Song, Won Seok Kang, Geum Youn Gwak, Myung Ji Goh, Yong Han Paik, Joon Hyeok Lee, Dong Hyun Sinn. Glycemic Burden and Clinical Outcomes of Early Stage Hepatocellular Carcinoma after Curative Treatment. Cancers 2024; 16(15): 2652 doi: 10.3390/cancers16152652
5
Shenyu Zhang, Guibin Yang, Ruipeng Song, Wei Wang, Fanzheng Meng, Dalong Yin, Jiabei Wang, Shugeng Zhang, Wei Cai, Yao Liu, Dayong Luo, Jizhou Wang, Lianxin Liu. Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experience. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241258394
6
Kunpeng Cao, Liuxi Wu, Xinyue Wang, Hongyan Deng, Ya Yuan, Lu Li, Chaoli Xu, Xinhua Ye. Risk Factors for Early Recurrence After Radical Resection of Hepatocellular Carcinoma Based on Preoperative Contrast-Enhanced Ultrasound and Clinical Features. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241281327
7
Kelley Núñez, Michael Schneider, Tyler Sandow, Juan Gimenez, Mina Hibino, Daniel Fort, Ari Cohen, Paul Thevenot. α-Fetoprotein, α-Fetoprotein-L3, and Des-γ-Carboxy Prothrombin Stratify Hepatocellular Carcinoma Treatment Response and Progression Risk. Gastro Hep Advances 2024; 3(3): 316 doi: 10.1016/j.gastha.2023.11.018
8
Jin-Lei Wang, Jia-Ping Yan, Jia-Ru Fan, Xiang Li, Xu Guo, Jia-Wei Li, Yun-Xiaojian Wu, Jing-Jie Wang, Yu-Lu Chen, Li Li, Cong Lin, Xin-Liang Qu, Ji-Hong Liu, Yan-Liang Zhang, Ying-Yi Yuan, Hua-Ge Yu, Yu-Xi Chen, Yi-Xuan Cai, Xiang-Di Zhang, Si Zhao, Zi-Hang Xu, Li Ma, Na Ma, Diao-Mei Guo, Lian-Sheng Ma. 2023: A year of accomplishments for the 13 Science Citation Index Expanded- and Emerging Sources Citation Index-indexed <i>Baishideng</i> journals. World Journal of Gastroenterology 2024; 30(1): 9-16 doi: 10.3748/wjg.v30.i1.9
9
Xinxin Wang, Yanyan Yu, Yuqing Tao, Yueqi Wang, Chunhui Zhang, Yali Cui, Yang Zhou. Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients. Journal of Hepatocellular Carcinoma 2023; : 2323 doi: 10.2147/JHC.S434955
10
Yuan Tian, Yaoqun Wang, Ningyuan Wen, Shaofeng Wang, Bei Li, Geng Liu. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12162-4
11
Juan Jose Urquijo-Ponce, Carlos Alventosa-Mateu, Mercedes Latorre-Sánchez, Inmaculada Castelló-Miralles, Moisés Diago. Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma. World Journal of Gastroenterology 2024; 30(19): 2512-2522 doi: 10.3748/wjg.v30.i19.2512
12
Yuanyue Guan, Jiaxi Li, Bin Sun, Kaikun Xu, Yonghong Zhang, Haijing Ben, Yingmei Feng, Mengcheng Liu, Shanshan Wang, Yuxue Gao, Zhongping Duan, Yang Zhang, Dexi Chen, Yanjun Wang. HBx-induced upregulation of MAP1S drives hepatocellular carcinoma proliferation and migration via MAP1S/Smad/TGF-β1 loop. International Journal of Biological Macromolecules 2024; 281: 136327 doi: 10.1016/j.ijbiomac.2024.136327
13
Francesco Vasuri, Stefano Chillotti, Thais Maloberti, Elisa Albertini, Giuliana Germinario, Matteo Cescon, Matteo Ravaioli, Dario de Biase, Antonia D’Errico. Beyond histology: A tissue algorithm predictive of post-surgical recurrence in hepatocellular carcinomas, including TERT promoter mutation. Virchows Archiv 2024;  doi: 10.1007/s00428-024-03791-y
14
Matheus D. Faleiro, Zuhaib M. Mir, Yara Azizieh, Stephanie E. Hiebert, Scott M. Livingstone, Mark J. Walsh, Boris L. Gala-Lopez. Oncologic Outcomes of Interventions to Decrease Allograft Ischemia-Reperfusion Injury within Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review. Current Oncology 2024; 31(6): 2895 doi: 10.3390/curroncol31060221
15
Meng Fan. Systemic immunoinflammatory index and prognostic nutrition index for predicting pathologic responses of patients with advanced gastric cancer after neoadjuvant therapy for advanced gastric cancer. American Journal of Cancer Research 2024; 14(8): 3922 doi: 10.62347/PAYM2267
16
Parissa Tabrizian, Adriana Pero, Myron Schwartz. Hepatic Resection for Hepatocellular Carcinoma. Clinics in Liver Disease 2024;  doi: 10.1016/j.cld.2024.08.008
17
Chunhong Tian, Yifan Yu, Yuqing Wang, Lunwei Yang, Ying Tang, Chengyang Yu, Gaofei Feng, Dayong Zheng, Xiongwen Wang. Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1352873
18
Zhan‐cheng Qiu, You‐wei Wu, Wei‐li Qi, Chuan Li. PIVKA‐II combined with tumor burden score to predict long‐term outcomes of AFP‐negative hepatocellular carcinoma patients after liver resection. Cancer Medicine 2024; 13(1) doi: 10.1002/cam4.6835
19
Zhi-Jun Zhang, Ba-Jin Wei, Zhi-Kun Liu, Ze-Feng Xuan, Lin Zhou, Shu-Sen Zheng. Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection. Hepatobiliary & Pancreatic Diseases International 2024;  doi: 10.1016/j.hbpd.2024.09.006
20
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
21
Andreea-Elena Scheau, Sandra Oana Jurca, Cristian Scheau, Ioana Gabriela Lupescu. Non-Surgical Treatment for Hepatocellular Carcinoma: What to Expect at Follow-Up Magnetic Resonance Imaging—A Pictorial Review. Applied Sciences 2024; 14(20): 9159 doi: 10.3390/app14209159
22
Jiahao Li, Yingnan Liu, Yuqi Qiu, Chao Qu, Jiarui Li. Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1487353
23
Meilin Yang, Xiaoyi Song, Fan Zhang, Mingan Li, Wuguang Chang, Zheyan Wang, Man Li, Hong Shan, Dan Li. Spatial proteomic landscape of primary and relapsed hepatocellular carcinoma reveals immune escape characteristics in early relapse. Hepatology 2024;  doi: 10.1097/HEP.0000000000000979
24
Ye Lu, Huanhuan Wang, Chenxia Li, Ferdos Faghihkhorasani, Cheng Guo, Xin Zheng, Tao Song, Qingguang Liu, Shaoshan Han. Preoperative and postoperative MRI-based models versus clinical staging systems for predicting early recurrence in hepatocellular carcinoma. European Journal of Surgical Oncology 2024; 50(9): 108476 doi: 10.1016/j.ejso.2024.108476
25
Sen Wang, Ying Zhao, Jiayi Li, Zongmin Yi, Jun Li, Can Zuo, Yu Yao, Ailian Liu. Self-supervised multi-modal feature fusion for predicting early recurrence of hepatocellular carcinoma. Computerized Medical Imaging and Graphics 2024; 118: 102457 doi: 10.1016/j.compmedimag.2024.102457
26
Jusen Nong, Kejian Yang, Tianman Li, Chenlu Lan, Xin Zhou, Junqi Liu, Haixiang Xie, Jianzhu Luo, Xiwen Liao, Guangzhi Zhu, Tao Peng. SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma. Aging 2023; 15(16): 8408 doi: 10.18632/aging.204978
27
Wei Shen, Lebin Yuan, Fei Cheng, Zhao Wu, Xiaodong Li. SRSF7 is a promising prognostic biomarker in hepatocellular carcinoma and is associated with immune infiltration. Genes & Genomics 2024; 46(1): 49 doi: 10.1007/s13258-023-01463-w
28
Myung Ji Goh, Hee Chul Park, Nalee Kim, Bong Kyung Bae, Moon Seok Choi, Jinsoo Rhu, Min Woo Lee, Woo Kyoung Jeong, Minji Kim, Kyunga Kim, Jeong Il Yu. Modified Albumin-Bilirubin Grade After Curative Treatment: Predicting the Risk of Late Intrahepatic Recurrence of Hepatocellular Carcinoma. Journal of Korean Medical Science 2024; 39(37) doi: 10.3346/jkms.2024.39.e251
29
Yutaka Endo, Muhammad Musaab Munir, Selamawit Woldesenbet, Erryk Katayama, Francesca Ratti, Hugo P Marques, François Cauchy, Vincent Lam, George A Poultsides, Minoru Kitago, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Ana Gleisner, Tom Hugh, Luca Aldrighetti, Feng Shen, Itaru Endo, Timothy M. Pawlik. Impact of Surgical Margin Width on Prognosis Following Resection of Hepatocellular Carcinoma Varies on the Basis of Preoperative Alpha-Feto Protein and Tumor Burden Score. Annals of Surgical Oncology 2023; 30(11): 6581 doi: 10.1245/s10434-023-13825-5
30
JiaYi Li, Yinxin Wu, Dingyin Zhang, Ziyan Zhang, Songqiang Li, Xi Cheng, Lihan Chen, Gang Zhou, Chengfu Yuan. The Roles of Cytoplasmic Polyadenylation Element Binding Protein 1 in Tumorigenesis. Mini-Reviews in Medicinal Chemistry 2024; 24(22): 2008 doi: 10.2174/0113895575293544240605112838
31
Mariana Michelle Ramírez-Mejía, Nahum Méndez-Sánchez. From prediction to prevention: Machine learning revolutionizes hepatocellular carcinoma recurrence monitoring. World Journal of Gastroenterology 2024; 30(7): 631-635 doi: 10.3748/wjg.v30.i7.631
32
Zhirong Zhang, Jiayao Yang, Rui Liu, Jing Ma, Kai Wang, Xiaojun Wang, Ni Tang. Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling. Genes & Diseases 2024; 11(5): 101285 doi: 10.1016/j.gendis.2024.101285
33
V. V. Breder, I. A. Pokataev, V. V. Petkau, M. Yu. Fedyanin, E. V. Ledin, V. E. Zagainov, S. V. Shapoval, D. A. Granov, P. V. Balakhnin, N. E. Kudashkin, I. V. Pogrebnyakov, N. V. Popova, E. A. Moroz. Advisory board resolution: The role of the adjuvant atezolizumab plus bevacizumab in patients with hepatocellular carcinoma at high risk of recurrence following surgical resection or ablation. Meditsinskiy sovet = Medical Council 2024; (22): 20 doi: 10.21518/ms2023-450
34
Wenying Qiao, Jiashuo Li, Yiqi Xiong, Jiasheng Zheng, Ronghua Jin, Caixia Hu. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation. Journal of Cancer Research and Clinical Oncology 2024; 150(5) doi: 10.1007/s00432-024-05760-z
35
Rokas Stulpinas, Ieva Jakiunaite, Agne Sidabraite, Allan Rasmusson, Dovile Zilenaite-Petrulaitiene, Kestutis Strupas, Arvydas Laurinavicius, Aiste Gulla. Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan Criteria. Current Oncology 2024; 31(9): 5344 doi: 10.3390/curroncol31090394
36
Yusra Zarlashat, Hassan Mushtaq, Linh Pham, Wasim Abbas, Keisaku Sato. Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies. International Journal of Molecular Sciences 2024; 25(13): 6830 doi: 10.3390/ijms25136830
37
Qian Ren, Yanjun Wang. Letter to the Editor: Comment on: “LI‑RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection”. Annals of Surgical Oncology 2023; 30(13): 8023 doi: 10.1245/s10434-023-14444-w
38
Kunpeng Cao, Xinyue Wang, Chaoli Xu, Liuxi Wu, Lu Li, Ya Yuan, Xinhua Ye. Ultrasound-based Radiomics Analysis for Assessing Risk Factors Associated With Early Recurrence Following Surgical Resection of Hepatocellular Carcinoma. Ultrasound in Medicine & Biology 2024; 50(12): 1964 doi: 10.1016/j.ultrasmedbio.2024.09.002
39
Luca Ielasi, Enrico Fulco, Nicola Reggidori, Marco Domenicali, Francesco Giuseppe Foschi. Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications. Gastroenterology Insights 2024; 15(3): 599 doi: 10.3390/gastroent15030044
40
Haibin Tu, Siyi Feng, Lihong Chen, Yujie Huang, Juzhen Zhang, Xiaoxiong Wu. Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction. Medicine 2023; 102(35): e34937 doi: 10.1097/MD.0000000000034937
41
Wei-Qiao Zhang, Qiao Zhang, Li Tan, Zhi-Feng Guan, Feng Tian, Hong-Tao Tang, Kun He, Wei-Qiang Chen. Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patients. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1289916
42
Dan Chen, Ayinuer Aierken, Hui Li, Ruihua Chen, Lei Ren, Kai Wang. Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1232390
43
Bingqiang Zhang, Boyang Zhu, Junmei Yu, He Liu, Yang Zhou, Guolong Sun, Yongchao Ma, Yansong Luan, Mengmeng Chen. A combined model of six serum microRNAs as diagnostic markers for hepatocellular carcinoma. Clinica Chimica Acta 2025; 565: 119977 doi: 10.1016/j.cca.2024.119977
44
Riccardo Nevola, Giovanni Tortorella, Valerio Rosato, Luca Rinaldi, Simona Imbriani, Pasquale Perillo, Davide Mastrocinque, Marco La Montagna, Antonio Russo, Giovanni Di Lorenzo, Maria Alfano, Maria Rocco, Carmen Ricozzi, Klodian Gjeloshi, Ferdinando Carlo Sasso, Raffaele Marfella, Aldo Marrone, Loreta Anesti Kondili, Nicolino Esposito, Ernesto Claar, Domenico Cozzolino. Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma. Biology 2023; 12(7): 984 doi: 10.3390/biology12070984
45
Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang. KDM4A-AS1 Promotes Cell Proliferation, Migration, and Invasion via the miR-4306/STX6 Axis in Hepatocellular Carcinoma . Critical Reviews in Eukaryotic Gene Expression 2024; 34(4): 55 doi: 10.1615/CritRevEukaryotGeneExpr.2024051414
46
Hao Li, Lixue Qiao, Minyu Kong, Haoran Fang, Zhiping Yan, Ran Guo, Wenzhi Guo. Construction and validation of a prognostic signature based on microvascular invasion and immune-related genes in hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-78467-3
47
Honghai Zhang, Shugui Sheng, Wenying Qiao, Yu Sun, Ronghua Jin. Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1395329
48
Lingbo Hu, Xuemei Li, Changhong Yang, Baoyong Zhou, Chengyou Du, Ning Jiang. Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1390938
49
Xi Wang, Xinqun Chai, Ji Zhang, Ruiya Tang, Qinjunjie Chen. Nomograms established for predicting microvascular invasion and early recurrence in patients with small hepatocellular carcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12655-2
50
Mingjie Lu, Chen Wang, Yi Zhuo, Junjiu Gou, Yingfeng Li, Jingqi Li, Xue Dong. Preoperative prediction power of radiomics and non-radiomics methods based on MRI for early recurrence in hepatocellular carcinoma: a systemic review and meta-analysis. Abdominal Radiology 2024; 49(10): 3397 doi: 10.1007/s00261-024-04356-y
51
Eloy Ruiz, Jorge Honles, Ramiro Fernández, Karla Uribe, Juan P. Cerapio, Karina Cancino, Juan Contreras-Mancilla, Sandro Casavilca-Zambrano, Francisco Berrospi, Pascal Pineau, Stéphane Bertani. A preoperative risk score based on early recurrence for estimating outcomes after resection of hepatocellular carcinoma in the non-cirrhotic liver. HPB 2024; 26(5): 691 doi: 10.1016/j.hpb.2024.02.010
52
Xinting Pan, En Hu, Yang Zhou, Ling Li, Xinhui Huang, Zhixiong Cai. The prognostic nutritional index as a predictor of efficacy and early recurrence for adjuvant transarterial chemoembolization in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2024; 48(6): 102344 doi: 10.1016/j.clinre.2024.102344
53
Jian-Hong Zhong. Adjuvant therapy for hepatocellular carcinoma: Dilemmas at the start of a new era. World Journal of Gastroenterology 2024; 30(8): 806-810 doi: 10.3748/wjg.v30.i8.806
54
Riccardo Nevola, Augusto Delle Femine, Valerio Rosato, Loreta Anesti Kondili, Maria Alfano, Davide Mastrocinque, Simona Imbriani, Pasquale Perillo, Domenico Beccia, Angela Villani, Rachele Ruocco, Livio Criscuolo, Marco La Montagna, Antonio Russo, Aldo Marrone, Ferdinando Carlo Sasso, Raffaele Marfella, Luca Rinaldi, Nicolino Esposito, Giuseppe Barberis, Ernesto Claar. Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?. Cancers 2023; 15(11): 2950 doi: 10.3390/cancers15112950
55
Belinda Sánchez-Pérez, José M Ramia. Does enhanced recovery after surgery programs improve clinical outcomes in liver cancer surgery?. World Journal of Gastrointestinal Oncology 2024; 16(2): 255-258 doi: 10.4251/wjgo.v16.i2.255
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345